CD19 and chronic myelogenous leukemia, BCR-ABL1 positive: There is, however a case report on an adult patient with lymphoid BP-CML harboring T315I mutation who achieved complete molecular remission and returned to chronic phase by anti-CD19 CAR-T therapy.